Lv1
48 积分 2023-01-26 加入
Anti-angiogenesis enhances the tumor immunotherapeutical effect of recombinant CD80 fusion protein
2天前
已完结
Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia
3个月前
已完结
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial
3个月前
已完结
To platform or not to platform: Strategic considerations for antibody formulation in early clinical development
3个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
3个月前
已完结
Recent progress in ITP treatment
4个月前
已完结
LILRB4 as a novel immunotherapeutic target for multiple diseases
6个月前
已完结
Secretogranin 2 binds LILRB4 resulting in immunosuppression
6个月前
已完结
LILRB4 specific overexpression in myeloid cells promotes tumor progression and immunosuppression in mouse models
7个月前
已完结
Design, Synthesis, and in vitro Evaluation of Multivalent Drug Linkers for High‐Drug‐Load Antibody–Drug Conjugates
7个月前
已完结
皖公网安备34019202002308
